ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Celecoxib

Also written as “celecoxib”, “Celecoxib 200mg” and “Celecoxib + Acetaminophen”.

Its studies are mostly in Osteoarthritis · Osteoarthritis, Knee · Low Back Pain · Migraine Disorders · Pain, Postoperative, led by 16 companies.

Drug pageCelecoxib: every studyMany companies study it; this page follows only the 66 they lead. All 383 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Aug 26, 200566 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Viatrisits history only320 open or runningphase 4since Aug 26, 2005Aug 26, 2005none ahead
Pfizer100 open or runningphase 4since Sep 9, 2005May 8, 2002none ahead
Dr. Reddy's Laboratoriesits history only40 open or runningphase 2since Jun 8, 2015Jun 8, 2015none ahead
NeuroSense Therapeuticsits history only40 open or runningphase 2since Nov 13, 2019Aug 29, 2019none ahead
Leidos Life Sciencesits history only30 open or runningphase 2since Oct 7, 2021Oct 7, 2021none ahead
BioDelivery Sciences Internationalits history only20 open or runningphase 3since Dec 27, 2016Dec 27, 2016none ahead
Laboratorios Silanes S.A. de C.V.its history only20 open or runningphase 3since Jun 26, 2024Jun 26, 2024none ahead
Aralez Pharmaceuticalsits history only10 open or runningphase 1since Aug 5, 2008Aug 5, 2008none ahead
Arthritis Innovationits history only10 open or runningphase 2since May 8, 2018May 8, 2018none ahead
Astellas Pharmaits history only10 open or runningphase 3since May 5, 2010May 5, 2010none ahead

Also a collaborator on its studies: AstraZeneca.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Pfizer only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. May 8, 2002First studies: 3 phase 2 studiesFirst studyNCT00036283, NCT00037180, NCT00038103
  2. Aug 26, 2005Phase 3 study in Osteoarthritis, KneeNCT00137410 · 200 enrolled · Italy
  3. Sep 9, 2005Phase 4 study in Osteoarthritis, HipNCT00174317 · 250 enrolled · United Kingdom
  4. Jun 8, 2007Phase 4 study in OsteoarthritisNCT00484718 · 6 enrolled · United States
  5. Mar 13, 2008Phase 2 study in SchizophreniaNCT00639483 · 270 enrolled · Argentina, Brazil, Germany and more
  6. Mar 28, 2008Phase 3 study in Spondylitis, AnkylosingNCT00648141 · 458 enrolled · Germany
  7. Apr 1, 2008Phase 3 study in Arthritis, JuvenileNCT00652925 · 225 enrolled · United States, Belgium, Brazil and more
  8. Apr 18, 2008Phase 2 study in ToothacheNCT00663767 · 250 enrolled · United States

TargetBeta

PTGS2 →read by rule
“Cyclooxygenase-2 inhibitor”ChEMBL 37, by rule

Other programs on PTGS2

ProgramCompanyFurthest phaseStudies
AcetaminophenruleJohnson & Johnsonphase 4136
IbuprofenrulePfizerphase 4113
AspirinruleBayerphase 484
MeloxicamruleBoehringer Ingelheimphase 467
EtoricoxibruleOrganonphase 435
dexketoprofenruleMenarini Groupphase 48
SulfasalazineruleBristol-Myers Squibbphase 47
dexibuprofenruleaponia-laboratories-incphase 46
BenzydamineruleAngelini Pharmaphase 44
DipyroneruleHypera Pharmaphase 44
PiroxicamruleTaisho Pharmaceuticalphase 44
FlurbiprofenruleGlaxoSmithKlinephase 312

Studies

All 10 Pfizer leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT00663767Toothache · United States2CompletedJun 20, 2008250
NCT00652925Arthritis, Juvenile · United States, Belgium, Brazil and more3CompletedApr 2004225
NCT00648141Spondylitis, Ankylosing · Germany3Completed458
NCT00639483Schizophrenia · Argentina, Brazil, Germany and more2Completed270
NCT00484718Osteoarthritis · United States4TerminatedJun 10, 20096
NCT00174317Osteoarthritis, Hip · United Kingdom4Completed250
NCT00137410Osteoarthritis, Knee · Italy3CompletedMar 2006200
NCT00038103Breast Neoplasms · United States, Belgium, Brazil and more2CompletedMar 2008111
NCT00037180Neoplasm Metastasis · United States2Terminated212
NCT00036283Precancerous Conditions · United States2Completed42

How it is read

Names in the registry

  • “Celecoxib”, 49 entries
  • “celecoxib”, 7 entries
  • “Celecoxib 200mg”, 3 entries
  • “Celecoxib + Acetaminophen”, 2 entries
  • “Comparator: celecoxib”, 2 entries

Codes read as this program: DFN15.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.